S'abonner

Potential Impact of the 2016 Consensus Definitions of Sepsis and Septic Shock on Future Sepsis Research - 23/09/17

Doi : 10.1016/j.annemergmed.2017.04.007 
Sandra L. Peake, FCICM, PhD a, b, , Anthony Delaney, PhD, FACEM b, c, Michael Bailey, MSc, PhD b, Rinaldo Bellomo, MD, FCICM b, d
for the

ARISE Investigators

  Investigators in the Australasian and Resuscitation in Sepsis Evaluation (ARISE) trial and their affiliations are listed in the Appendix.
V. Bennett, J. Board, P. McCracken, S. McGloughlin, V. Nanjayya, A. Teo, E. Hill, P. Jones, E. O’Brien, F. Sawtell, K. Schimanski, D. Wilson, R. Bellomo, S. Bolch, G. Eastwood, F. Kerr, L. Peak, H. Young, J. Edington, J. Fletcher, J. Smith, D. Ghelani, K. Nand, T. Sara, A. Cross, D. Flemming, M. Grummisch, A. Purdue, E. Fulton, K. Grove, A. Harney, K. Milburn, R. Millar, I. Mitchell, H. Rodgers, S. Scanlon, T. Coles, H. Connor, J. Dennett, A. Van Berkel, S. Barrington-Onslow, S. Henderson, J. Mehrtens, J. Dryburgh, A. Tankel, G. Braitberg, B. O’Bree, K. Shepherd, S. Vij, S. Allsop, D. Haji, K. Haji, J. Vuat, A. Bone, T. Elderkin, N. Orford, M. Ragg, S. Kelly, D. Stewart, N. Woodward, V.-P. Harjola, M. Okkonen, V. Pettilä, S. Sutinen, E. Wilkman, J. Fratzia, J. Halkhoree, S. Treloar, K. Ryan, T. Sandford, J. Walsham, C. Jenkins, D. Williamson, J. Burrows, D. Hawkins, C. Tang, A. Dimakis, A. Holdgate, S. Micallef, M. Parr, H. White, L. Morrison, K. Sosnowski, R. Ramadoss, N. Soar, J. Wood, M. Franks, A. Williams, C. Hogan, R. Song, A. Tilsley, D. Rainsford, N. Soar, R. Wells, J. Wood, J. Dowling, P. Galt, T. Lamac, D. Lightfoot, C. Walker, K. Braid, T. DeVillecourt, H.S. Tan, I. Seppelt, L.F. Chang, W.S. Cheung, S.K. Fok, P.K. Lam, S.M. Lam, H.M. So, W.W. Yan, A. Altea, B. Lancashire, C.D. Gomersall, C.A. Graham, P. Leung, S. Arora, F. Bass, Y. Shehabi, J. Isoardi, K. Isoardi, D. Powrie, S. Lawrence, A. Ankor, L. Chester, M. Davies, S. O’Connor, A. Poole, T. Soulsby, K. Sundararajan, J. Williams, J.H. Greenslade, C. MacIsaac, K. Gorman, A. Jordan, L. Moore, S. Ankers, S. Bird, A. Delaney, J. Dowling, T. Fogg, E. Hickson, T. Jewell, K. Kyneur, A. O’Connor, J. Townsend, E. Yarad, S. Brown, J. Chamberlain, J. Cooper, E. Jenkinson, E. McDonald, S. Webb, H. Buhr, J. Coakley, J. Cowell, D. Hutch, D. Gattas, M. Keir, D. Rajbhandari, C. Rees, S. Baker, B. Roberts, E. Farone, J. Holmes, J. Santamaria, C. Winter, A. Finckh, S. Knowles, J. McCabe, P. Nair, C. Reynolds, B. Ahmed, D. Barton, E. Meaney, A. Nichol, R. Harris, L. Shields, K. Thomas, S. Karlsson, A. Kuitunen, A. Kukkurainen, J. Tenhunen, S. Varila, J. Burrows, N. Ryan, C. Trethewy, J. Crosdale, J.C. Smith, M. Vellaichamy, J. Furyk, G. Gordon, L. Jones, S. Senthuran, S. Bates, J. Butler, C. French, A. Tippett, J. Kelly, J. Kwans, M. Murphy, D. O’Flynn, C. Kurenda, T. Otto, S. Peake, V. Raniga, P. Williams, H.F. Ho, A. Leung, H. Wu

a University of Adelaide and The Queen Elizabeth Hospital, Adelaide, South Australia 
b Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia 
c Royal North Shore Hospital and University of Sydney, Sydney, New South Wales, Australia 
d Austin Hospital, Melbourne, Victoria, Australia 

Corresponding Author.

Abstract

Study objective

The influence of the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) on the conduct of future sepsis research is unknown. We seek to examine the potential effect of the new definitions on the identification and outcomes of patients enrolled in a sepsis trial.

Methods

This was a post hoc analysis of the Australasian Resuscitation in Sepsis Evaluation (ARISE) trial of early goal-directed therapy that recruited 1,591 adult patients presenting to the emergency department (ED) with early septic shock diagnosed by greater than or equal to 2 systemic inflammatory response syndrome criteria and either refractory hypotension or hyperlactatemia. The proportion of participants who would have met the Sepsis-3 criteria for quick Sequential Organ Failure Assessment (qSOFA) score, sepsis (an increased Sequential Organ Failure Assessment score ≥2 because of infection) and septic shock before randomization, their baseline characteristics, interventions delivered, and mortality were determined.

Results

There were 1,139 participants who had a qSOFA score of greater than or equal to 2 at baseline (71.6% [95% confidence interval {CI} 69.4% to 73.8%]). In contrast, 1,347 participants (84.7% [95% CI 82.9% to 86.4%]) met the Sepsis-3 criteria for sepsis. Only 1,010 participants were both qSOFA positive and met the Sepsis-3 criteria for sepsis (63.5% [95% CI 61.1% to 65.8%]). The Sepsis-3 definition for septic shock was met at baseline by 203 participants (12.8% [95% CI 11.2% to 14.5%]), of whom 175 (86.2% [95% CI 81.5% to 91.0%]) were also qSOFA positive. Ninety-day mortality for participants fulfilling the Sepsis-3 criteria for sepsis and septic shock was 20.4% (95% CI 18.2% to 22.5%) (274/1,344) and 29.6% (95% CI 23.3% to 35.8% [60/203]) versus 9.4% (95% CI 5.8% to 13.1%) (23/244) and 17.1% (95% CI 15.1% to 19.1% [237/1,388]), respectively, for participants not meeting the criteria (risk differences 11.0% [95% CI 6.2% to 14.8%] and 12.5% [95% CI 6.3% to 19.4%], respectively).

Conclusion

Most ARISE participants did not meet the Sepsis-3 definition for septic shock at baseline. However, the majority fulfilled the new sepsis definition and mortality was higher than for participants not fulfilling the criteria. A quarter of participants meeting the new sepsis definition did not fulfill the qSOFA screening criteria, potentially limiting its utility as a screening tool for sepsis trials with patients with suspected infection in the ED. The implications of the new definitions for patients not eligible for recruitment into the ARISE trial are unknown.

Le texte complet de cet article est disponible en PDF.

Plan


 Please see page 554 for the Editor’s Capsule Summary of this article.
 Supervising editor: Alan E. Jones, MD
 Author contributions: SLP, AD, and RB conceived the study. MB conducted the statistical analyses. SLP drafted the article and all authors contributed substantially to its revision. SLP takes responsibility for the paper as a whole.
 All authors attest to meeting the four ICMJE.org authorship criteria: (1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND (2) Drafting the work or revising it critically for important intellectual content; AND (3) Final approval of the version to be published; AND (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist.
 Readers: click on the link to go directly to a survey in which you can provide 3SFPP87 to Annals on this particular article.
 A podcast for this article is available at www.annemergmed.com.


© 2017  American College of Emergency Physicians. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 70 - N° 4

P. 553 - octobre 2017 Retour au numéro
Article précédent Article précédent
  • An Emergency Department Validation of the SEP-3 Sepsis and Septic Shock Definitions and Comparison With 1992 Consensus Definitions
  • Daniel J. Henning, Michael A. Puskarich, Wesley H. Self, Michael D. Howell, Michael W. Donnino, Donald M. Yealy, Alan E. Jones, Nathan I. Shapiro
| Article suivant Article suivant
  • HIV Prevention and Treatment: The Evolving Role of the Emergency Department
  • Kristi Stanley, Meredith Lora, Stephen Merjavy, Jennifer Chang, Sanjay Arora, Michael Menchine, Kathleen R. Jacobson

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.